Network pharmacology and experimental evaluation strategies to decipher the underlying pharmacological mechanism of Traditional Chinese Medicine CFF-1 against prostate cancer-Reference-Cited by-同舟云学术

Network pharmacology and experimental evaluation strategies to decipher the underlying pharmacological mechanism of Traditional Chinese Medicine CFF-1 against prostate cancer

Published:2024-03-13 Issue:6 Volume:16 Page:5387-5411
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Wei Yong¹,Zhu Mingxia²,Chen Ye³,Ji Qianying⁴,Wang Jun⁴,Shen Luming¹,Yang Xin¹,Hu Haibin¹,Zhou Xin⁵⁶,Zhu Qingyi¹

Affiliation:

1. Department of Urology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China

2. Department of Radiation Oncology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China

3. The First Medicine College, Taizhou Campus of Nanjing University of Traditional Chinese Medicine, Taizhou 225300, China

4. Department of Urology, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing 210029, China

5. Department of Oncology, The Affiliated Suqian First People’s Hospital of Nanjing Medical University, Suqian 223812, China

6. Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China

Publisher

Impact Journals, LLC

Reference43 articles.

1. Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer.;Goodman;Ann Oncol,2020

2. Improved survival for patients with de novo metastatic prostate cancer in the last 20 years.;Brasso;Eur J Cancer,2017

3. Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.;Kasivisvanathan;Eur Urol Oncol,2020

4. Commentary on "Integrative clinical genomics of advanced prostate cancer". Robinson D, Van Allen EM, Wu YM, Schultz N, Lonigro RJ, Mosquera JM, Montgomery B, Taplin ME, Pritchard CC, Attard G, Beltran H, Abida W, Bradley RK, Vinson J, Cao X, Vats P, Kunju LP, Hussain M, Feng FY, Tomlins SA, Cooney KA, Smith DC, Brennan C, Siddiqui J, Mehra R, Chen Y, Rathkopf DE, Morris MJ, Solomon SB, Durack JC, Reuter VE, Gopalan A, Gao J, Loda M, Lis RT, Bowden M, Balk SP, Gaviola G, Sougnez C, Gupta M, Yu EY, Mostaghel EA, Cheng HH, Mulcahy H, True LD, Plymate SR, Dvinge H, Ferraldeschi R, Flohr P, Miranda S, Zafeiriou Z, Tunariu N, Mateo J, Perez-Lopez R, Demichelis F, Robinson BD, Schiffman M, Nanus DM, Tagawa ST, Sigaras A, Eng KW, Elemento O, Sboner A, Heath EI, Scher HI, Pienta KJ, Kantoff P, de Bono JS, Rubin MA, Nelson PS, Garraway LA, Sawyers CL, Chinnaiyan AM.Cell. 21 May 2015;161(5):1215-1228.;Aronson;Urol Oncol,2017

5. Exploring the possible molecular targeting mechanism of Saussurea involucrata in the treatment of COVID-19 based on bioinformatics and network pharmacology.;Zhu;Comput Biol Med,2022